Life ScienceCompany
Ipsen M&A Summary
Ipsen has acquired 11 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.
Ipsen’s largest acquisition to date was in 2023, when it acquired Albireo Pharma for $952M. Ipsen has acquired in 3 different US states, and 5 countries. The Company’s most targeted sectors include life science (100%).
Ipsen Business Overview
Where is Ipsen headquartered?
Ipsen is headquartered in Boulogne-Billancourt, France.
What is Ipsen’s revenue?
Ipsen disclosed revenue of 3,306M EUR for 2023 and 3,157M EUR for 2022.
How many employees does Ipsen have?
Ipsen has 5,325 employees.
What sector is Ipsen in?
Ipsen is a life science company.
When was Ipsen founded?
Ipsen was founded in 1929.
M&A Summary
-
M&A Total Activity13
- M&A Buy Activity11
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 5
- M&A Buy/Sell Connections 5
- M&A Advisors 8
Unlimited Searches
